nach oben

Erschienen in:

01.08.2018 | News item

Health Canada: risk of acute pancreatitis with SGLT2 inhibitors

Einloggen, um Zugang zu erhalten

Excerpt

There appears to be a link between use of SGLT2¹ inhibitors and the potential risk of acute pancreatitis, says Health Canada. …

SGLT2 = sodium-glucose transporter-2

Government of Canada. Summary Safety Review - SGLT2 inhibitors (canagliflozin, dapagliflozin and empagliflozin) - Health Canada. Internet Document : 20 Jul 2018. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00204

Titel: Health Canada: risk of acute pancreatitis with SGLT2 inhibitors
Publikationsdatum: 01.08.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-49835-9